238 related articles for article (PubMed ID: 15329742)
1. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants.
Efird MM; Heerens AT; Gordon PV; Bose CL; Young DA
J Perinatol; 2005 Feb; 25(2):119-24. PubMed ID: 15329742
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants.
Ng PC; Lee CH; Bnur FL; Chan IH; Lee AW; Wong E; Chan HB; Lam CW; Lee BS; Fok TF
Pediatrics; 2006 Feb; 117(2):367-75. PubMed ID: 16452355
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
4. Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial.
Bonsante F; Latorre G; Iacobelli S; Forziati V; Laforgia N; Esposito L; Mautone A
Neonatology; 2007; 91(4):217-21. PubMed ID: 17568152
[TBL] [Abstract][Full Text] [Related]
5. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
[TBL] [Abstract][Full Text] [Related]
6. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
7. Disseminated candidal infections and intravenous hydrocortisone in preterm infants.
Botas CM; Kurlat I; Young SM; Sola A
Pediatrics; 1995 Jun; 95(6):883-7. PubMed ID: 7761215
[TBL] [Abstract][Full Text] [Related]
8. Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants.
Fanaroff JM; Wilson-Costello DE; Newman NS; Montpetite MM; Fanaroff AA
Pediatrics; 2006 Apr; 117(4):1131-5. PubMed ID: 16585307
[TBL] [Abstract][Full Text] [Related]
9. Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns.
Baker CF; Barks JD; Engmann C; Vazquez DM; Neal CR; Schumacher RE; Bhatt-Mehta V
J Perinatol; 2008 Jun; 28(6):412-9. PubMed ID: 18337742
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.
Watterberg KL; Gerdes JS; Gifford KL; Lin HM
Pediatrics; 1999 Dec; 104(6):1258-63. PubMed ID: 10585975
[TBL] [Abstract][Full Text] [Related]
11. Metabolic responses to early and high protein supplementation in a randomized trial evaluating the prevention of hyperkalemia in extremely low birth weight infants.
Blanco CL; Falck A; Green BK; Cornell JE; Gong AK
J Pediatr; 2008 Oct; 153(4):535-40. PubMed ID: 18589451
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term consequences of hypotension in ELBW infants.
Fanaroff AA; Fanaroff JM
Semin Perinatol; 2006 Jun; 30(3):151-5. PubMed ID: 16813974
[TBL] [Abstract][Full Text] [Related]
13. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
Cordero L; Nankervis CA; Delooze D; Giannone PJ
J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
[TBL] [Abstract][Full Text] [Related]
16. Correlation between early neonatal diet and atopic symptoms up to 5-7 years of age in very low birth weight infants: follow-up of randomized, double-blind study.
Kwinta P; Sawiec P; Klimek M; Lis G; Cichocka-Jarosz E; Pietrzyk JJ
Pediatr Allergy Immunol; 2009 Aug; 20(5):458-66. PubMed ID: 19490477
[TBL] [Abstract][Full Text] [Related]
17. Early systemic hypotension and vasopressor support in low birth weight infants: impact on neurodevelopment.
Pellicer A; Bravo MC; Madero R; Salas S; Quero J; Cabañas F
Pediatrics; 2009 May; 123(5):1369-76. PubMed ID: 19403504
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular instability after patent ductus arteriosus ligation in preterm infants: the role of hydrocortisone.
Satpute MD; Donohue PK; Vricella L; Aucott SW
J Perinatol; 2012 Sep; 32(9):685-9. PubMed ID: 22094490
[TBL] [Abstract][Full Text] [Related]
19. Hypotension in the newborn: who needs hydrocortisone?
Aucott SW
J Perinatol; 2005 Feb; 25(2):77-8. PubMed ID: 15660104
[No Abstract] [Full Text] [Related]
20. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study.
Rios DR; Kaiser JR
J Pediatr; 2015 Apr; 166(4):850-5. PubMed ID: 25641242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
